209 related articles for article (PubMed ID: 21340480)
1. Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer.
Reeder-Hayes KE; Bainbridge J; Meyer AM; Amos KD; Weiner BJ; Godley PA; Carpenter WR
Breast Cancer Res Treat; 2011 Aug; 128(3):863-71. PubMed ID: 21340480
[TBL] [Abstract][Full Text] [Related]
2. Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer.
Black DM; Jiang J; Kuerer HM; Buchholz TA; Smith BD
JAMA Surg; 2014 Aug; 149(8):788-96. PubMed ID: 25073831
[TBL] [Abstract][Full Text] [Related]
3. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
[TBL] [Abstract][Full Text] [Related]
4. Differential receipt of sentinel lymph node biopsy within practice-based research networks.
Meyer AM; Reeder-Hayes KE; Liu H; Wheeler SB; Penn D; Weiner BJ; Carpenter WR
Med Care; 2013 Sep; 51(9):812-8. PubMed ID: 23942221
[TBL] [Abstract][Full Text] [Related]
5. Surgeon specialization and use of sentinel lymph node biopsy for breast cancer.
Yen TW; Laud PW; Sparapani RA; Nattinger AB
JAMA Surg; 2014 Feb; 149(2):185-92. PubMed ID: 24369337
[TBL] [Abstract][Full Text] [Related]
6. Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy.
Rescigno J; Zampell JC; Axelrod D
Ann Surg Oncol; 2009 Mar; 16(3):687-96. PubMed ID: 19101768
[TBL] [Abstract][Full Text] [Related]
7. Disparities in the Use of Sentinel Lymph Node Dissection for Early Stage Breast Cancer.
Nayyar A; Strassle PD; Schlottmann F; Jadi J; Moses CG; Black JA; Gallagher KK; McGuire KP
J Surg Res; 2020 Oct; 254():31-40. PubMed ID: 32408028
[TBL] [Abstract][Full Text] [Related]
8. Perioperative outcomes and disparities in utilization of sentinel lymph node biopsy in minimally invasive staging of endometrial cancer.
Albright BB; Nasioudis D; Byrne ME; Latif NA; Ko EM; Haggerty AF
Gynecol Oncol; 2020 Dec; 159(3):758-766. PubMed ID: 32981697
[TBL] [Abstract][Full Text] [Related]
9. Disparities in receipt of lymph node biopsy among early-stage female breast cancer patients.
Halpern MT; Chen AY; Marlow NS; Ward E
Ann Surg Oncol; 2009 Mar; 16(3):562-70. PubMed ID: 18998064
[TBL] [Abstract][Full Text] [Related]
10. Understanding age and race disparities in the application of sentinel lymph node biopsy in breast cancer.
Radhakrishnan A; Silverman P; Pollack CE; Pfoh ER; Shenk R; Thompson CL
J Investig Med; 2016 Dec; 64(8):1241-1245. PubMed ID: 27466395
[TBL] [Abstract][Full Text] [Related]
11. The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
Mann JM; Wu X; Christos P; Nagar H
Clin Breast Cancer; 2018 Aug; 18(4):e477-e493. PubMed ID: 29031423
[TBL] [Abstract][Full Text] [Related]
12. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
13. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database.
Yi M; Giordano SH; Meric-Bernstam F; Mittendorf EA; Kuerer HM; Hwang RF; Bedrosian I; Rourke L; Hunt KK
Ann Surg Oncol; 2010 Oct; 17 Suppl 3(0 3):343-51. PubMed ID: 20853057
[TBL] [Abstract][Full Text] [Related]
14. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
[TBL] [Abstract][Full Text] [Related]
15. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
16. The interplay between hospital and surgeon factors and the use of sentinel lymph node biopsy for breast cancer.
Yen TWF; Li J; Sparapani RA; Laud PW; Nattinger AB
Medicine (Baltimore); 2016 Aug; 95(31):e4392. PubMed ID: 27495053
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection.
Kootstra JJ; Hoekstra-Weebers JE; Rietman JS; de Vries J; Baas PC; Geertzen JH; Hoekstra HJ
Ann Surg Oncol; 2010 Sep; 17(9):2384-94. PubMed ID: 20221902
[TBL] [Abstract][Full Text] [Related]
18. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
[TBL] [Abstract][Full Text] [Related]
19. Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging.
Vanderveen KA; Schneider PD; Khatri VP; Goodnight JE; Bold RJ
Ann Surg Oncol; 2006 Nov; 13(11):1450-6. PubMed ID: 17009150
[TBL] [Abstract][Full Text] [Related]
20. Utilization of sentinel lymph node biopsy in patients with ductal carcinoma in situ undergoing mastectomy.
Shah DR; Canter RJ; Khatri VP; Bold RJ; Yang AD; Martinez SR
Ann Surg Oncol; 2013 Jan; 20(1):24-30. PubMed ID: 23054103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]